<code id='0D16506298'></code><style id='0D16506298'></style>
    • <acronym id='0D16506298'></acronym>
      <center id='0D16506298'><center id='0D16506298'><tfoot id='0D16506298'></tfoot></center><abbr id='0D16506298'><dir id='0D16506298'><tfoot id='0D16506298'></tfoot><noframes id='0D16506298'>

    • <optgroup id='0D16506298'><strike id='0D16506298'><sup id='0D16506298'></sup></strike><code id='0D16506298'></code></optgroup>
        1. <b id='0D16506298'><label id='0D16506298'><select id='0D16506298'><dt id='0D16506298'><span id='0D16506298'></span></dt></select></label></b><u id='0D16506298'></u>
          <i id='0D16506298'><strike id='0D16506298'><tt id='0D16506298'><pre id='0D16506298'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:374
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip
          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

          RogelioV.Solis/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          A letter from the executive editor: The 2023 STATUS List

          Aftermonthsofvigorousdeliberations,I’mthrilledtoannounceour2023STATUSList—thedefinitiverosterofleade